{"id":"W2323802693","doi":"10.3899/jrheum.120249","title":"Infliximab in Psoriatic Arthritis","year":2012,"lang":"en","type":"review","venue":"Journal of Rheumatology Supplement","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Medicine; Psoriatic arthritis; Infliximab; Placebo; Psoriasis; Rheumatology; Internal medicine; Rheumatoid arthritis; Adverse effect; TNF inhibitor; Adalimumab; Etanercept; Randomized controlled trial; Arthritis; Gastroenterology; Tumor necrosis factor alpha; Dermatology; Pathology; Alternative medicine","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":true,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001343557,0.000419526,0.004076173,0.001163944,0.00004680335,0.0000292623,0.0003020472,0.0003322184,0.002192639],"category_scores_gemma":[0.0002494368,0.0003103302,0.0007644962,0.0003182863,0.0002053004,0.0001798985,0.000103206,0.001224646,0.000154959],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002899595,"about_ca_system_score_gemma":0.001035783,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00006237205,"about_ca_topic_score_gemma":0.0001407344,"domain_scores_codex":[0.9953653,0.000430995,0.002601245,0.000209929,0.0006289622,0.0007635672],"domain_scores_gemma":[0.9975394,0.0003450835,0.001204621,0.0003467029,0.000175693,0.0003885261],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00007629512,0.0003889998,0.002238266,0.005639748,0.0007263007,0.0004341452,0.0002328539,1.036461e-7,8.544136e-8,0.0009010225,0.004792029,0.9845701],"study_design_scores_gemma":[0.003728975,0.0005124797,0.00002706555,0.03176801,0.0001104265,0.02467083,0.0001394739,9.052911e-7,9.080702e-7,0.0001411515,0.9386935,0.0002062706],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0003393824,0.9973014,0.00002232744,0.0006679308,0.0008113908,0.000716628,0.00002948955,0.00001000197,0.0001014492],"genre_scores_gemma":[0.001057032,0.9974825,0.001125865,0.0000292662,0.00008328779,0.00006297808,0.00005936443,0.00005886276,0.00004084452],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9843639,"threshold_uncertainty_score":0.9999349,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04221363469434143,"score_gpt":0.3549296525239564,"score_spread":0.3127160178296149,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}